about
Inflammatory cytokines induce production of CHI3L1 by articular chondrocytesElucidation of the potential roles of matrix metalloproteinases in skeletal biologyLocal expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritisHuman breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activityStrong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitorThe role of human HtrA1 in arthritic diseaseCritical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossificationHigh disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damageSalivary proteomics in bisphosphonate-related osteonecrosis of the jaw.Progress in matrix metalloproteinase research.Periploca forrestii saponin ameliorates CIA via suppressing proinflammatory cytokines and nuclear factor kappa-B pathways.Characterization of human osteoarthritic cartilage using optical and magnetic resonance imaging.Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium.Matrix Degradative Enzymes and Their Inhibitors during Annular Inflammation: Initial Step of Symptomatic Intervertebral Disc Degeneration.Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κBRegulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study.Mitochondrial respiratory chain dysfunction modulates metalloproteases -1, -3 and -13 in human normal chondrocytes in culture.Effects of cyclic tensile strain on chondrocyte metabolism: a systematic reviewMatrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritisMetalloproteinases, inflammation, and rheumatoid arthritis.MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative polymerase chain reactionSclareol exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model.Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography.RelA is required for IL-1beta stimulation of Matrix Metalloproteinase-1 expression in chondrocytes.Anti-inflammatory effects of polyphenolic-enriched red raspberry extract in an antigen-induced arthritis rat model.The role of matrix metalloproteinase 14 polymorphisms in susceptibility to intervertebral disc degeneration in the Chinese Han populationMatrix metalloproteinases in renal development.Experimental progressive emphysema in BALB/cJ mice as a model for chronic alveolar destruction in humans.Pravastatin suppresses matrix metalloproteinase expression and activity in human articular chondrocytes stimulated by interleukin-1βDrug delivery strategies for cathepsin inhibitors in joint diseases.Proteinases in the joint: clinical relevance of proteinases in joint destructionRole of keratinocyte-fibroblast cross-talk in development of hypertrophic scar.The pathogenic role of angiogenesis in rheumatoid arthritis.A cell-matrix model of anabolic and catabolic dynamics during cartilage biomolecule regulationInvestigation of MMP-1 genetic polymorphisms and protein expression and their effects on the risk of Kashin-Beck disease in the northwest Chinese Han population.CIINE Reflects Collagenase-Specific CII Breakdown in Cartilage Explant and Whole Body of CanineSerum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment.Persisting high levels of synovial fluid markers after cartilage repair: a pilot study
P2860
Q24338555-A33C2AD1-6324-4D6D-9559-58DB039B7AD7Q24795770-9A6B558B-DA18-43C4-B709-4B20D9AF9602Q24799214-976C4D1A-0C3D-46F3-92B0-070198A9CEA7Q24803810-C50F73FB-6976-4499-9D40-341A2F68AA6FQ24805749-2B32A8BA-237E-4D37-8732-77778994DB17Q28288792-E0646C25-723A-439D-9420-C071B15F129BQ28505336-A3F9E2C7-A695-47BE-A75F-31AB41BC8AD9Q31113598-AE26EDF8-FF48-4451-B4C7-28E1180E2D2BQ33555823-993CB825-4C82-488F-9C5D-5B04A07F0866Q33608536-5C7A1D57-5F79-4480-9D78-88F62FB3EE4FQ33626416-8AD5B492-EA36-44ED-9A8C-BE2550827F1EQ33839599-AF931F82-B453-414D-91C4-48763CA0A66FQ33898784-597323CB-85DB-40B2-B45B-43C9C8B475A5Q34037252-5D4131C7-42D1-4960-B6A5-1504CABFCAE0Q34374198-16CA8A53-8759-4D4E-9ECD-234E52914C6AQ34896489-06231D39-D632-4A5C-8564-364F41FFB9B2Q34928795-9EB521CB-64BB-442A-90E1-F7BC2479F6CEQ35231500-82DA9005-D498-46C8-A5EE-8F874240356CQ35552183-DFF50827-1125-4BDB-930D-7F66ABF437A6Q35553483-34F57729-0938-4850-9CAE-65A18858204CQ35555490-6485DCCB-A371-4FAC-BC93-8C70648463B8Q35605620-BB78E7EB-D5F4-4067-AC46-D78D0B4D672DQ35629992-CE2B43B4-50D4-4361-BC1A-8D3FABE91BC2Q35632005-91AD8F10-E1E2-419E-BC9F-11A74C4B7A87Q35637026-1340EA28-1DBE-4DE2-8D3F-3BD298768B6BQ35783187-CD8023B8-537B-4FB7-B8E0-BD5493B96CC9Q35836496-1B9B0540-8D4F-46A5-873D-324945FA4769Q35992128-A8607FD0-A914-469D-BB7B-FFE9F5DFFA31Q36069463-0AE7ADFF-642F-4F92-B783-6A354E67C827Q36122901-E160A31C-3E47-4481-92DE-F6DE3864BE18Q36189250-C2CF0F85-74F1-4D9F-AC72-1D3A8EFAB3B8Q36316921-23716C72-1FF9-42D6-B996-793128C87502Q36401848-2D172708-63A8-406E-9AB6-05CF2D2D4006Q36922420-B8696E38-9887-4A7E-A0E2-96FB7BA3105BQ36934777-36045E6D-BEA0-4AE9-8225-006B03C71DBFQ36939058-EB412761-367F-4221-8524-4E7715C7AFA4Q36955186-3781DDE0-1A0E-4A08-ADDC-84E848F0FDB3Q36961195-3C2CCE24-BD3F-4E30-B0E1-662D52E84DB4Q36993320-6E0BFE7E-3384-4F84-823A-A9C4E815712DQ37011640-4B162F3C-2589-4B09-9B54-2F2681BCB15F
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Matrix metalloproteinases in arthritic disease
@ast
Matrix metalloproteinases in arthritic disease
@en
Matrix metalloproteinases in arthritic disease
@nl
type
label
Matrix metalloproteinases in arthritic disease
@ast
Matrix metalloproteinases in arthritic disease
@en
Matrix metalloproteinases in arthritic disease
@nl
prefLabel
Matrix metalloproteinases in arthritic disease
@ast
Matrix metalloproteinases in arthritic disease
@en
Matrix metalloproteinases in arthritic disease
@nl
P2093
P2860
P356
P1476
Matrix metalloproteinases in arthritic disease
@en
P2093
George Butler
Gillian Murphy
Jan Stracke
Mike Hutton
Susan Atkinson
Vera Knäuper
William English
P2860
P2888
P304
P356
10.1186/AR572
P478
P577
2002-05-09T00:00:00Z
P5875
P6179
1018933167